Your Article Summary
See Latest ArticlesAntiviral therapy in compensated and decompensated cirrhotic patients with chronic HCV infection
Expert Opinion in Pharmacotherapy, 07/01/09
Iacobellis A et al. - Treatment is only recommended for a well-compensated liver cirrhosis, whereas antiviral therapy is commonly not implemented in cirrhotics with signs of liver decompensation, over the concern that the use of peginterferon and ribavirin might expose patients to severe treatment-related side effects. This review focuses on data available to support both efficacy and safety of antiviral therapy in both compensated and decompensated cirrhotic patients.
Today in Hepatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Small-for-size liver graft injury--impact on tumor behavior
Transplantation Reviews, 12/07/09
Quality Improvement Guidelines for Radiofrequency Ablation of Liver Tumours
Cardiovascular and Interventional Radiology, 12/07/09
Role of ethanol in kava hepatotoxicity
Phytotherapy Research, 12/07/09